Letter to the editor: ‘challenges and opportunities in the treatment of ventilator-associated pneumonia’

Mark L. MeterskyDepartment of Medicine, Division of Pulmonary and Critical Care, University of Connecticut School of Medicine, Farmington, CT, USACorrespondence[email protected]
View further author information

Andre C. KalilDepartment of Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USAView further author information

References

Schreiber MP, Shorr AF. Challenges and opportunities in the treatment of ventilator-associated pneumonia. Expert Rev Anti Infect Ther. 2017;15:23–32.
PubMed Web of Science ®Google Scholar
Kalil AC, Metersky ML, Klompas M, et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:575–582.
PubMed Web of Science ®Google Scholar
Kollef MH, Chastre J, Clavel M, et al. A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care. 2012;16:R218.
PubMed Web of Science ®Google Scholar
Dimopoulos G, Poulakou G, Pneumatikos IA, et al. Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest. 2013;144:1759–1767.
PubMed Web of Science ®Google Scholar
Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. Jama. 2003;290:2588–2598.
PubMed Web of Science ®Google Scholar
Dear Healthcare Professional Letter. 2012. [cited 2017 Jan 6]. Available from: www.fda.gov/downloads/drugs/drugsafety/ucm286277.pdf.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter to the editor: ‘challenges and opportunities in the treatment of ventilator-associated pneumonia’

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter to the editor: ‘challenges and opportunities in the treatment of ventilator-associated pneumonia’

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date